Beckman Coulter
Roche, Beckman Coulter Deals Put Alzpath at Center of Plasma P-tau 217 Alzheimer's Testing Space
Premium
The company looks to tackle the Alzheimer's market by supplying global diagnostics firms with the antibodies needed for their tests in the space.
Danaher Launches US, UK Laboratories for Precision Medicine Test Development
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
Beckman Coulter Licensing Alzpath's P-tau 217 Antibody for Use in Alzheimer's Blood Tests
Beckman Coulter will use the antibody as part of a p-tau 217 in vitro diagnostic on its DxI 9000 Immunoassay Analyzer to aid in the diagnosis of the disease.